Xlife Sciences AG (XLS) | Finanzwire

Basculer en Français

9527	Companies
187412	Keywords
119446	Articles
100176	Press releases

Home
Companies
Xlife Sciences AG

BRIEF

published on 12/12/2025 at 08:35, 3 days 7 hours ago

Xlife Sciences Unveils Award-Winning Liver PET Tracer

Innovation Award Xlife Sciences DAZAmed Liver PET Tracer
PRESS RELEASE

published on 12/12/2025 at 08:30, 3 days 7 hours ago

Award-Winning Liver PET Tracer Highlights the Strength of Our Innovation Portfolio
Xlife Sciences AG announces the award-winning world's first liver-specific PET tracer, DAZAmed, highlighting scientific and commercial potential. A breakthrough in nuclear medicine for liver disease imaging

Xlife Sciences AG Award-winning Nuclear Medicine DAZAmed Liver PET Tracer
BRIEF

published on 12/08/2025 at 07:05, 7 days 9 hours ago

Xlife Sciences AG Transfers 12 Project Companies to Grupo Landsteiner

Global Expansion Xlife Sciences Grupo Landsteiner Life Sciences Platform Biotech Acquisition
PRESS RELEASE

published on 12/08/2025 at 07:00, 7 days 9 hours ago

Xlife Sciences AG Announces Exit of 12 Project Companies to Grupo Landsteiner and the Creation of a Scalable Transcontinental Life Sciences Platform
Xlife Sciences AG announces strategic exit of 12 projects to Grupo Landsteiner, forming a transcontinental life sciences platform with a NASDAQ listing in 2026

Life Sciences Nasdaq Listing Xlife Sciences AG Strategic Exit Grupo Landsteiner
BRIEF

published on 12/01/2025 at 07:05, 14 days 9 hours ago

Xlife Sciences AG Unveils NeuroMex for Early Alzheimer’s Detection

Healthcare Innovation Xlife Sciences Market Opportunity NeuroMex Alzheimer’s Detection
PRESS RELEASE

published on 12/01/2025 at 07:00, 14 days 9 hours ago

Xlife Sciences AG Delivers Breakthrough in Early Alzheimer’s Detection, Unlocking Major Market Opportunity
Xlife Sciences AG and saniva diagnostics GmbH announce NeuroMex, the world's first certified medical device for early Alzheimer's detection, with 83.5% accuracy in identifying early-stage Alzheimer's

Healthcare Clinical Trials Xlife Sciences AG Alzheimer's Detection NeuroMex
BRIEF

published on 11/28/2025 at 13:15, 17 days 2 hours ago

Xlife Sciences AG Updates on VERAXA Biotech's NASDAQ Listing

Nasdaq Listing Business Combination SEC Filing Oncology Therapeutics VERAXA Biotech
PRESS RELEASE

published on 11/28/2025 at 13:10, 17 days 2 hours ago

Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process Following U.S. Government Shutdown
Xlife Sciences AG updates on VERAXA Biotech AG's NASDAQ listing process post U.S. Government Shutdown, SEC responds to Form F-4 filing, progress towards business combination with Voyager Acquisition Corp

Nasdaq SEC Xlife Sciences AG VERAXA Biotech AG Voyager Acquisition Corp.
BRIEF

published on 10/16/2025 at 07:05, 1 month 30 days ago

Xlife Sciences AG Releases 2024 ESG Report Highlighting Sustainable Growth

Environmental Impact Social Responsibility Sustainable Growth Xlife Sciences ESG Report 2024
PRESS RELEASE

published on 10/16/2025 at 07:00, 1 month 30 days ago

Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a Strategic Core
Xlife Sciences AG publishes 2024 ESG Report showcasing sustainable value creation through integrating ESG principles into corporate strategy and portfolio management in life sciences sector

Life Sciences Xlife Sciences AG ESG Principles Sustainable Value Creation 2024 ESG Report

1 2 ... 7

Accesswire

Published on 12/15/2025 at 15:00, 1 hour 5 minutes ago

Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 1 hour 5 minutes ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 1 hour 35 minutes ago

Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix
Published on 12/15/2025 at 14:00, 2 hours 5 minutes ago

Dateline Delivers Further High-Grade Intercepts from North Pipe at Colosseum
Published on 12/15/2025 at 13:30, 2 hours 35 minutes ago

Greenlane Announces Results of Annual Meeting of Stockholders, Canopy Growth Co Founder Bruce Linton Joins Greenlane's Board of Directors

View all ACCESSWIRE

EQS Group

Published on 12/15/2025 at 15:50, 15 minutes ago

Original-Research: Cabka N.V. (von First Berlin Equity Research GmbH): Kaufen
Published on 12/15/2025 at 15:49, 16 minutes ago

Mutares submits an irrevocable offer to acquire Venator Ultramarine Blue Pigments business from Venator France SAS
Published on 12/15/2025 at 15:45, 20 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated
Published on 12/15/2025 at 15:44, 21 minutes ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Published on 12/15/2025 at 15:43, 22 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc

Les Echos

Published on 12/15/2025 at 11:50, 4 hours 15 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of November 30, 2025
Published on 12/12/2025 at 18:00, 2 days 22 hours ago

Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 09:15, 3 days 6 hours ago

CHANGE IN THE SHARE CAPITAL
Published on 12/11/2025 at 19:23, 3 days 20 hours ago

Eiffage is joining the CAC 40 index
Published on 12/11/2025 at 08:30, 4 days 7 hours ago

Edenred and Daimler Truck join forces to accelerate the rollout of charging infrastructure for electric trucks in Europe

View all LES ECHOS COMFI WIRE